Rare Diseases 2021: maintaining the human element in decentralised trials
AGTC’s director of patient enrollment discusses the importance of the human touch in decentralised rare disease clinical trials.
Simplifying Clinical Trials
Metabolic disorders therapy area most suitable for use of digital health tech in clinical trials: poll
Small world: how decentralisation is improving paediatric clinical trials
Groundbreaking UK “mega-trial” will test existing drugs as new treatments for MS
Arch Biopartners secures approval to amend LSALT Peptide trial protocols
How to increase efficiency and agility in oncology trials
Why going digital is the right step for the pharma industry
How a digital approach to risk management is transforming the pharma industry
